Clinical Trial Update: Targeted Microbiome Transplant in Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a targeted microbiome transplant for atopic dermatitis has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis (AD) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-05-22